ACD Labs Logo
MENU

High Throughput Experimentation Made Easier Than Ever Before

Software for automated planning, execution, and analysis of high throughput experiments

Katalyst D2D is a web-based software application that offers a single interface for high throughput experimentation from Design to Decide.

Delivering comprehensive process development and execution, enabled by live analytical data.

Katalyst D2D enables you to automate manual tasks and eliminates transcription between the multiple systems you are currently using to plan and execute high throughput experiments—array-based chemistry or parallel synthesis.

Katalyst is purpose-built to automate and analyze your entire high throughput experiment workflow in one interface. It helps you design, plan, and execute array-based experiments by integrating with your lab automation—informatics systems and laboratory hardware.

Katalyst also supports high throughput analysis. It will help automatically analyze and assemble all your analytical data, from entire studies, in one place. So, you can comprehensively get from Design to Decide in one application.

Resources

This webinar will discuss how our new software application - Katalyst D2D - gets you from design to decision faster than ever before. If you are currently involved in high throughput (HT)/parallel synthesis, looking to improve automation productivity gains, or considering investments in automation; don't miss this webinar!
Watch on Demand

In this article Ruairi Mackenzie speaks with ACD/Labs' Andrew Anderson about Anderson's unique vantage point into how technology affects the analytical chemistry field. Read on for a discussion of how the day-to-day life of a chemist has been changed by technologies like AI and automation and how budding chemists can get their skillset up to scratch to handle the changing face of analytical science.
Read more

Technology Networks spoke with ACD/Labs' Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.
Read more